Search GTHP
GUIDED THERAPEUTICS INC
OTC · CIK 924515
Last close0.22
Daily change-0.03 (-11.29%)
10 Years gain-37.68%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
GTHP · STANDARD
SIC 3845 · Electromedical & Electrotherapeutic Apparatus · Fiscal year end 1231
Fundamental
55.4Momentum
100.0Acceleration
100.0Confidence
62.0Annual Revenue16
Quarterly Revenue52
Annual CFO10
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth25.0 / 25
Quality12.5 / 25
Capital Efficiency16.9 / 20
Balance Sheet1.1 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 32004.2373 percentage points.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 2.2599 percentage points.
Heavy share dilution · HIGHDiluted share count increased 41.3598%.
Low interest coverage · HIGHInterest coverage is -3.5393x.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM2,850%OK
Revenue CAGR 3Y289.3%OK
Gross Margin64.41%OK
Operating Margin-1,145.76%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Y814.42%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y41.36%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $767,000.00 | $571,000.00 | -$2.37M | -$1.07M | -$1.07M | 74.45% | -309.26% | -139.5% | n/a | 78.41M |
| 2025 FY Dec 31, 2024 | $7,000.00 | $2,000.00 | -$2.11M | -$1.12M | -$1.12M | 28.57% | -30,114.29% | -15,985.71% | n/a | 57.34M |
| 2024 FY Dec 31, 2023 | $98,000.00 | $36,000.00 | -$3.46M | -$1.75M | n/a | 36.73% | -3,527.55% | n/a | n/a | 51.13M |
| 2023 FY Dec 31, 2022 | $13,000.00 | -$68,000.00 | -$3.33M | -$1.48M | -$1.51M | -523.08% | -25,638.46% | -11,615.38% | n/a | 32.51M |
| 2022 FY Dec 31, 2021 | $81,000.00 | $20,000.00 | -$2.36M | -$1.59M | -$1.61M | 24.69% | -2,916.05% | -1,982.72% | n/a | 13.38M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $177,000.00 | sum latest 4 fiscal quarters Revenue | OK | 0001477932-26-004958, 0001477932-25-008196 |
| Revenue Growth TTM | 2,850% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001477932-26-004958, 0001477932-25-008196 |
| Revenue CAGR 3Y | 289.3% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001477932-26-001723 |
| Revenue CAGR 5Y | 49.71% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001477932-26-001723 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001477932-26-001723 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001477932-26-004958, 0001477932-25-008196 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 64.41% | Gross Profit / Revenue | OK | 0001477932-26-004958, 0001477932-25-008196 |
| Operating Margin | -1,145.76% | Operating Income / Revenue | OK | 0001477932-26-004958, 0001477932-25-008196 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001477932-26-004958 |
| Interest Coverage | -3.54x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 0.09x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.23x | (Cash + Short-term Investments) / Total Debt | OK | 0001477932-26-004958 |
| Revenue per Diluted Share | $0.00 | Revenue / Diluted Shares | OK | 0001477932-26-004958, 0001477932-25-008196 |